REVB

NASDAQ · Biotechnology

Revelation Biosciences Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$1.65

+0.18 (+12.24%)

As of Feb 8, 2:34 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 6 86%

Hold 1 14%

Sell 0 0%

Price Target

Analyst Price Target +518.8% upside

Low Target $7.91

Average Target $10.21

High Target $15.75

Current Price $1.65

Current
$1.65

Target
$10.21

$7.91 $10.21 avg $15.75

Scenario Analysis

Bear Case

$7.91

379.4%

Low target

Base Case

$10.21

+518.8%

Avg target

Bull Case

$15.75

+854.5%

High target

Risk/Reward

2.3x

Favorable

Price in Context

52-Week High

$11.30

-85.4% from high

52-Week Low

$4.89

+-66.3% from low

Target vs 52W High

$10.21

-9.6% vs high

Next Earnings Report

Mar 4, 2026 · After Market Close

16d

until earnings

EPS Est: $-3.73

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	37	68%	$257.58	+15.3%
AMGN Amgen Inc	Hold	41	54%	$190.87	-50.3%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+137.8%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	77%	$438.34	-8.3%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-90.2%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-68.8%
INSM Insmed Inc	Strong Buy	27	93%	$143.40	-4.3%
BIIB Biogen Inc	Hold	42	48%	$91.45	-54.5%